Gilead CEO Milligan out ahead of turnaround bid
In an unexpected statement ahead of its second quarter earnings release Wednesday evening, Gilead Sciences said its well-liked CEO John Milligan will step down and...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.